SEC Info - Kirk Randal J, et al. - ‘SC 13D’ on 12/12/11 re: Synthetic Biologics, Inc.

SEC Info℠

Home

Help

Please Sign In

Kirk Randal J, et al. – ‘SC 13D’ on 12/12/11 re: Synthetic Biologics, Inc.

On: Monday, 12/12/11, at 5:26pm ET · Accession #: 1140361-11-57083 · File #: 5-50777

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/12/11  Kirk Randal J                     SC 13D                 2:152K Synthetic Biologics, Inc.         Summit Fin’l Printing
          Intrexon Corp

General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      Adeona Pharmaceuticals Inc Schedule 13D 12-7-2011   HTML     79K 
 2: EX-4        Instrument Defining the Rights of Security Holders  HTML      8K

Filing Submission 0001140361-11-057083 – SGML Text

Original SGML Text submitted by:	Broadridge Financial Solutions, Inc. (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Kirk Randal J, et al. – ‘SC 13D’ on 12/12/11 re: Synthetic Biologics, Inc.

On: Monday, 12/12/11, at 5:26pm ET · Accession #: 1140361-11-57083 · File #: 5-50777

Previous ‘SC 13D’: ‘SC 13D/A’ on 8/17/11 · Next: ‘SC 13D/A’ on 1/25/12 · Latest: ‘SC 13D/A’ on 6/30/23

General Statement of Beneficial Ownership — Schedule 13DFiling Table of Contents

To view the SGML, please refresh this page.

General Statement of Beneficial Ownership — Schedule 13D
Filing Table of Contents

To view the SGML, please refresh
this page.